Recent Presentations Made by ACI on Taxes, Solvency and Broadband Stimulus

Dr. Joseph P. Fuhr, “Why Biosimilars Will Have a Smaller Competitive Edge Than Generics,” presented at CBI’s Second Annual Summit on Biosimilars and Follow-on biologics, Baltimore, based on an article coauthored by Dr. Erwin A. Blackstone and published in the Journal of Health Care Finance, Winter 2008, pp. 84-95. Slides available. Steve Pociask, “Why Solvency Matters,” […]